Probiotics and inflammatory bowel disease: a natural fit?

References

• Griffiths AM, Buller HB. Inflammatory Bowel Disease. In: Pediatric Gastrointestinal Disease. Walker WA, Durie PR, Hamilton JR et al. (Eds), BC Decker, Ontario, Canada (2000).
   Google Scholar
• Sartor RB. Pathogenesis and immune mechanisms of chronic inflammatory bowel diseases. Am. J. Gastroenterol. 92, S5–S11 (1997).
   PubMed Web of Science ®Google Scholar
• Ogura Y, Bonen DK, Inohara N et al. A frameshift mutation in Nod2 associated with susceptibility to Crohn’s disease. Nature 411, 603–606 (2001).
   PubMed Web of Science ®Google Scholar
• Inohara N, Ogura Y, Fontalba A et al. Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn’s disease. J. Biol. Chem. 278, 5509–5512 (2003).
   PubMed Web of Science ®Google Scholar
• Rath HC, Schultz M, Freitag R et al. Different subsets of enteric bacteria induce and perpetuate colitis in rats and mice. Infect. Immun. 69, 2277–2285 (2001).
   PubMed Web of Science ®Google Scholar
• Madsen KL, Doyle JS, Tavernini MM et al. Antibiotic therapy attenuates colitis in interleukin-10 gene-deficient mice. Gastroenterology 118, 1094–1105 (2000).
   PubMed Web of Science ®Google Scholar
• Eng WR, Day AS, Leach S et al. Exclusive enteral nutrition alters the intestinal microbiota of children with Crohn’s disease. Gastroenterology 128, A511 (2005).
   PubMedGoogle Scholar
• Markowitz JE, Bengmark S. Probiotics in health and disease in the pediatric patient. Pediatr. Clin. North Am. 49, 127–141 (2002).
   PubMedGoogle Scholar
• Lewis SJ, Freedman AR. Review article: the use of biotherapeutic agents in the prevention and treatment of gastrointestinal disease. Aliment. Pharmacol. Ther. 12, 807–822 (1998).
   Google Scholar
• Mack DR, Ahrne S, Hyde L, Wei S, Hollingsworth MA. Extracellular MUC3 mucin secretion follows adherence of Lactobacillus strains to intestinal epithelial cells in vitro. Gut 52, 827–833 (2003).
   PubMed Web of Science ®Google Scholar
• Day AS. Use of complementary and alternative therapies by children attending gastroenterology outpatient clinics. J. Paediatr. Child. Health 38, 343–346 (2002).
   PubMed Web of Science ®Google Scholar
• Day AS, Whitten KE, Bohane TD. Use of complementary and alternative medicines by children and adolescents with inflammatory bowel disease. J. Paediatr. Child. Health 40, 681–684 (2004).
   PubMed Web of Science ®Google Scholar
• Sawyer MG, Gannoni AF, Toogood IR, Antoniou G, Rice M. The use of alternative therapies by children with cancer. Med. J. Aust. 160, 320–322 (1994).
   PubMed Web of Science ®Google Scholar
• Szajewska H, Mrukowicz JZ. Probiotics in the treatment and prevention of acute infectious diarrhea in infants and children: a systematic review of published randomized, double-blind, placebo-controlled trials. J. Pediatr. Gastroenterol. Nutr. 33(Suppl. 2), S17–S25 (2001).
   PubMed Web of Science ®Google Scholar
• Oksanen PJ, Salminen S, Saxelin M et al. Prevention of travellers’ diarrhoea by Lactobacillus GG. Ann. Med. 22, 53–56 (2001).
   Google Scholar
• Surawicz CM. Probiotics, antibiotic-associated diarrhoea and Clostridium difficile diarrhoea in humans. Best Prac. Res. Clin. Gastroenterol. 17, 775–783 (1990).
   Google Scholar
• D’Souza AL, Rajkumar C, Cooke J, Bulpitt CJ. Probiotics in prevention of antibiotic-associated diarrhoea: meta-analysis. Br. Med. J. 324, 1361–1366 (2002).
   PubMed Web of Science ®Google Scholar
• Rosenfeldt V, Benfeldt E, Valerius NH, Paerregaard A, Michaelsen KF. Effect of probiotics on gastrointestinal symptoms and small intestinal permeability in children with atopic dermatitis. J. Pediatr. 145, 612–616 (2004).
   PubMed Web of Science ®Google Scholar
• Weston S, Halbert A, Richmond P, Prescott SL. Effects of probiotics on atopic dermatitis: a randomised controlled trial. Arch. Dis. Child. 90, 892–897 (2005).
   PubMed Web of Science ®Google Scholar
• Madsen KL, Doyle JS, Jewell LD, Tavernini MM, Fedorak RN. Lactobacillus species prevents colitis in interleukin-10 gene deficient mice. Gastroenterology 116, 1107–1114 (1999).
   PubMed Web of Science ®Google Scholar
• Holma R, Salmenpera P, Lohi J, Vapaatalo H, Korpela R. Effects of Lactobacillus rhamnosus GG and Lactobacillus reuteri R2LC on acetic acid-induced colitis in rats. Scand. J. Gastroenterol. 36, 630–655 (2001).
   PubMedGoogle Scholar
• Mao Y, Nobaek S, Kasravi B et al. The effects of Lactobacillus strains and oat fiber on methotrexate-induced enterocolitis in rats. Gastroenterology 111, 334–344 (1996).
   PubMed Web of Science ®Google Scholar
• Madsen KL, Cornish A, Soper P et al. Probiotic bacteria enhance murine and human intestinal epithelial barrier function. Gastroenterology 121, 580–591 (2001).
   PubMed Web of Science ®Google Scholar
• Gionchetti P, Rizzello F, Venturi A et al. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology 119, 305–309 (2000).
   PubMed Web of Science ®Google Scholar
• Gionchetti P, Rizzello F, Helwig U et al. Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial. Gastroenterology 124, 1202–1209 (2003).
   PubMed Web of Science ®Google Scholar
• Friedman G, George J. Treatment of refractory ‘pouchitis’ with prebiotic and probiotic therapy. Gastroenterology 118, A778 (2000).
   Google Scholar
• Malchow HA. Crohn’s disease and Escherichia coli. A new approach in therapy to maintain remission of colonic Crohn’s disease? J. Clin. Gastroenterol. 25, 653–658 (1997).
   PubMed Web of Science ®Google Scholar
• Gupta P, Andrew H, Kirschner BS, Guandalini S. Is Lactobacillus GG helpful in children with Crohn’s disease? Results of a preliminary, open-label study. J. Pediatr. Gastroenterol. Nutr. 31, 453–457 (2000).
   PubMed Web of Science ®Google Scholar
• Campieri M, Rizzello F, Venturi A et al. Combination of antibiotic and probiotic treatment is efficacious in prophylaxis of post-operative recurrence of Crohn’s disease: a randomised controlled study versus mesalazine. Gastroenterology 118, A781 (2000).
   Web of Science ®Google Scholar
• Bousvaros A, Guandalini S, Baldassano RN et al. A randomized, double-blinded trial of Lactobacillus GG versus placebo in addition to standard maintenance therapy for children with Crohn’s disease. Inflamm. Bowel Dis. 11, 833–839 (2005).
   PubMed Web of Science ®Google Scholar
• Rembacken BJ, Snelling AM, Hawkey PM, Chalmers DM, Axon AT. Nonpathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial. Lancet 354, 635–639 (1999).
   PubMed Web of Science ®Google Scholar
• Venturi A, Gionchetti P, Rizello F et al. Impact on the composition of the fecal flora by a new probiotic preparation: preliminary data on maintenance treatment of patients with ulcerative colitis. Aliment Pharmacol. Ther. 13, 1103–1108 (1999).
   PubMed Web of Science ®Google Scholar
• Bibiloni R, Fedorak RN, Tannock GW et al. VSL#3 probiotic-mixture induces remission in patients with active ulcerative colitis. Am. J. Gastroenterol. 100, 1539–1546 (2005).
   PubMed Web of Science ®Google Scholar